Suppr超能文献

脂质过氧化在卤代烯烃半胱氨酸共轭物诱导的肾近端小管细胞死亡中的作用。

Role of lipid peroxidation in renal proximal tubule cell death induced by haloalkene cysteine conjugates.

作者信息

Groves C E, Lock E A, Schnellmann R G

机构信息

Department of Physiology and Pharmacology, College of Pharmacy, University of Georgia, Athens 30602.

出版信息

Toxicol Appl Pharmacol. 1991 Jan;107(1):54-62. doi: 10.1016/0041-008x(91)90330-h.

Abstract

The role of lipid peroxidation in the cell death produced by the haloalkene cysteine conjugates S-(1,2,3,4,4-pentachlorobutadienyl)-L-cysteine (PCBC), S-(1,2-dichlorovinyl)-L-cysteine (DCVC), S-(1,1,2,2-tetrafluoroethyl)-L-cysteine (TFEC), and S-(2-chloro-1,1,2-trifluoroethyl)-L-cysteine (CTFC) was investigated using a well-defined suspension of rabbit renal proximal tubules. PCBC, DCVC, TFEC, and CTFC at a concentration of 25 microM caused renal proximal tubular death (measured by lactate dehydrogenase release) in a time-dependent (2-6 hr) manner and increased tubular malondialdehyde (MDA) formation prior to and during cell death (1-6 hr). The antioxidants butylated hydroxytoluene (BHT) (25 microM) and N,N'-diphenyl-1,4-phenylenediamine (DPPD) (50 microM) and the iron chelator deferoxamine (1 mM) blocked the increase in MDA formation produced by these four compounds. BHT and deferoxamine delayed PCBC-, DCVC-, and CTFC-induced cell death but had no effect on the overall extent of cell death. BHT and deferoxamine had no effect on TFEC-induced cell death. DPPD had effects similar to those of deferoxamine on DCVC- and CTFC-induced cell death, but, unlike deferoxamine, DPPD significantly reduced PCBC- and TFEC-induced cell death. This difference in the effect of DPPD may not be related to its effects as an antioxidant. The antioxidant, putative cellular phospholipase inhibitor and calmodulin antagonist, chlorpromazine (100 microM), blocked the increase in MDA formation and after 6 hr decreased by 50% the degree of cell death produced by PCBC, DCVC, TFEC, and CTFC. Furthermore, chlorpromazine could be added 1 or 2 hr after DCVC or PCBC and still provide the same degree of protection. The enhanced protection with chlorpromazine, in relation to deferoxamine and BHT, may be related to its actions as a phospholipase inhibitor and/or calmodulin antagonist. These results show that iron-dependent lipid peroxidation plays a role in PCBC-, DCVC-, and CTFC-induced rabbit renal proximal tubule cell death. In contrast, iron-dependent lipid peroxidation plays no role in TFEC-induced proximal tubule cell death. These observations suggest that mechanisms other than peroxidative damage may predominate in the cell death produced by these four compounds.

摘要

使用明确的兔肾近端小管悬浮液,研究了脂质过氧化在卤代烯烃半胱氨酸共轭物S-(1,2,3,4,4-五氯丁二烯基)-L-半胱氨酸(PCBC)、S-(1,2-二氯乙烯基)-L-半胱氨酸(DCVC)、S-(1,1,2,2-四氟乙基)-L-半胱氨酸(TFEC)和S-(2-氯-1,1,2-三氟乙基)-L-半胱氨酸(CTFC)所致细胞死亡中的作用。浓度为25微摩尔的PCBC、DCVC、TFEC和CTFC以时间依赖性方式(2至6小时)导致肾近端小管死亡(通过乳酸脱氢酶释放来测定),并在细胞死亡之前及期间(1至6小时)增加肾小管丙二醛(MDA)的形成。抗氧化剂丁基化羟基甲苯(BHT,25微摩尔)、N,N'-二苯基-1,4-苯二胺(DPPD,50微摩尔)以及铁螯合剂去铁胺(1毫摩尔)可阻断这四种化合物所引起的MDA形成增加。BHT和去铁胺延迟了PCBC、DCVC和CTFC诱导的细胞死亡,但对细胞死亡的总体程度没有影响。BHT和去铁胺对TFEC诱导的细胞死亡没有作用。DPPD对DCVC和CTFC诱导的细胞死亡的作用与去铁胺相似,但与去铁胺不同的是,DPPD显著降低了PCBC和TFEC诱导的细胞死亡。DPPD作用的这种差异可能与其作为抗氧化剂的作用无关。抗氧化剂、假定的细胞磷脂酶抑制剂和钙调蛋白拮抗剂氯丙嗪(100微摩尔)可阻断MDA形成的增加,并且在6小时后使PCBC、DCVC、TFEC和CTFC所导致的细胞死亡程度降低了50%。此外,氯丙嗪可在DCVC或PCBC作用后1或2小时添加,仍能提供相同程度的保护。与去铁胺和BHT相比,氯丙嗪增强的保护作用可能与其作为磷脂酶抑制剂和/或钙调蛋白拮抗剂的作用有关。这些结果表明,铁依赖性脂质过氧化在PCBC、DCVC和CTFC诱导的兔肾近端小管细胞死亡中起作用。相比之下,铁依赖性脂质过氧化在TFEC诱导的近端小管细胞死亡中不起作用。这些观察结果表明,除了过氧化损伤之外的机制可能在这四种化合物所致的细胞死亡中占主导地位。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验